shareholder fraud

6 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Babcock & Wilcox Faces Securities Lawsuit Over Applied Digital Contract Disclosures

Rosen Law Firm urges $BW investors to join class action lawsuit alleging false statements regarding Applied Digital power generation contract before June 15 deadline.
BWBWNBBWpAsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··The Gross Law Firm

UHG Hit With Securities Class Action Over Alleged Devaluation Scheme

The Gross Law Firm filed a securities lawsuit against United Homes Group, alleging controlling shareholder Nieri made false statements while orchestrating a forced sale.
UHGUHGWWsecurities class actionshareholder fraud
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Llp

UHG Plunges 52% on $1.18 Stanley Martin Deal; Shareholders Sue Over Alleged Misrepresentation

United Homes Group plummets 52% after agreeing to $1.18/share acquisition; shareholders sue controlling shareholder over alleged misrepresentation.
UHGUHGWWclass action lawsuitacquisition
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Llp

Lawsuit Filed Against Franklin BSP Realty Trust Over Alleged Dividend Misrepresentation

Robbins LLP sues Franklin BSP Realty Trust ($FBRT) for allegedly misleading investors about dividend sustainability before cutting payout 44%.
FBRTFBRTpEclass action lawsuitmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··The Law Offices Of Frank R. Cruz

Shareholder Lawsuits Against Lakeland Industries, Navan Inc. Approach Lead Plaintiff Deadline

Class action lawsuits filed against Lakeland Industries and Navan Inc. allege misleading disclosures. Lead plaintiff deadline is April 24, 2026.
LAKENAVNclass action lawsuitmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Llp

uniQure Investors Face April Deadline in Securities Class Action Over FDA Disclosure Claims

Securities lawsuit against uniQure alleges misleading FDA disclosure statements about gene therapy candidate AMT-130. Stock fell 49% after November FDA feedback; investors must file claims by April 13, 2026.
QUREclass action lawsuitshareholder fraud